This is a good defensive stock and has good valuations. Their earnings may be impacted by some of their reinvestment plans. The US GDP numbers are still strong. The battle continues with Amazon. At this level it is fairly valued.

There has been a tail wind in the commodity sector as of late. They have done a great job to deleverage their business. As China slows down this could cause some issues. It is fairly valued here.

The traditional retailers have been under pressure. They did a deep dive into evaluating this company about a year ago and concluded some of the US investments were not performing as well as expected. They have mortgages a lot of their real estate the base business is not growing. It is fair valued, but he does not like this name right now.

He has been recommending this for a while, buying a company at less than 9 times earnings. A really good business at a discounted price right now. The headwinds of the headline risk against pharma has played out. A strong buy for the next 5 years investment horizon.

An eventful day yesterday, trading down 20%. His analysis after the Cambridge Analytica scandal suggested buying near $120 would be a good target. Their head count is up 45% and the AI investment will take time and money. If you own it, hold it, but he is waiting for better value.

Amazon’s recent disappointing result has impacted this stock. There is no guidance to when it will become profitable, so it is very speculative at this point. There is some concern by analysts how they are reporting their financial results. He is staying away.

The short traders like this one – and he thinks they are right. They are burning a ton of cash, but have met their production numbers. It is not the most transparent company and there are now more companies coming into the electric care space and they are not developing autonomous driving technology. He is staying away.